NCT05124782

Brief Summary

The purpose of this study is to optimize the care of patients with RA seen in virtual consultation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 22, 2021

Completed
27 days until next milestone

First Posted

Study publicly available on registry

November 18, 2021

Completed
12 days until next milestone

Study Start

First participant enrolled

November 30, 2021

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 22, 2023

Completed
Last Updated

September 15, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

October 22, 2021

Last Update Submit

September 8, 2025

Conditions

Keywords

Rheumatoid arthritisVirtual consultationTelemedicinePatient reported outcome

Outcome Measures

Primary Outcomes (1)

  • Rate of face to face consultation, hospitalization and therapeutic modifications

    The primary outcome will be the rate of face to face consultation, hospitalization and therapeutic modifications decided by the rheumatologist during the virtual consultation

    Inclusion

Study Arms (1)

Patients with rheumatoid arthritis

Patients seen in virtual consultation

Other: Rheumatoid Arthritis Impact of Disease questionnaire

Interventions

Rheumatoid Arthritis Impact of Disease questionnaire

Patients with rheumatoid arthritis

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with rheumatoid arthritis followed in a tertiary center (University Hospital Cochin)

You may qualify if:

  • Patients with rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria
  • Follow-up in the rheumatology department of Cochin Hospital
  • Affiliated with a social security scheme
  • Non-opposition to participating in the study
  • Patients with a valid email address (registration to the virtual consultation system)

You may not qualify if:

  • Opposition to participate to this research
  • Inability to understand or speak French
  • Patient under tutor or curator ship
  • patients under medical state help

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rheumatology Department, Cochin Hospital

Paris, IDF, 75014, France

Location

MeSH Terms

Conditions

Arthritis, Rheumatoid

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Jérôme AVOUAC, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 22, 2021

First Posted

November 18, 2021

Study Start

November 30, 2021

Primary Completion

November 22, 2023

Study Completion

November 22, 2023

Last Updated

September 15, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations